Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Trellus HealthLSE:TRLS Forward Dividend Yield % is 0.00% as of Sep. 02, 2026. The stock has 2 warning signs investors should review. Among 283 Healthcare Providers & Services companies, Trellus Health ranks worse than 353356.54% on this metric.
As of today (2026-09-02), the Forward Annual Dividend Yield of Trellus Health is 0.00%.
As of today (2026-09-02), the Trailing Annual Dividend Yield of Trellus Health is 0.00%.
LSE:TRLS's Forward Dividend Yield % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.4 * Ranked among companies with meaningful Forward Dividend Yield % only.
Trellus Health (LSE:TRLS) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Trellus Health Forward Dividend Yield % Related Terms
LSE:TRLS vs VEEV, BTSG, TEM: Forward Dividend Yield % Comparison
For the Health Information Services subindustry, Trellus Health's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trellus Health Forward Dividend Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Trellus Health's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Trellus Health's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.00% mean?
Trellus Health (LSE:TRLS) has a Forward Dividend Yield % of 0.00% as of Sep. 02, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Trellus Health and its competitors. According to the industry distribution chart, Trellus Health ranks #999999 out of 283 companies in the Healthcare Providers & Services industry.
Is Trellus Health's Forward Dividend Yield % too high?
Trellus Health's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Trellus Health ranks #999999 out of 283 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Trellus Health's Forward Dividend Yield % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Trellus Health ranks #999999 out of 283 companies for Forward Dividend Yield %. This places Trellus Health in the lower half of its industry. The industry median Forward Dividend Yield % is 2.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Healthcare Providers & Services company?
The median Forward Dividend Yield % among Healthcare Providers & Services companies is 2.40, based on 283 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Trellus Health and its competitors. For the Healthcare Providers & Services industry, the median Forward Dividend Yield % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trellus Health's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trellus Health stock overvalued right now?
Trellus Health (LSE:TRLS) has a current Forward Dividend Yield % of 0.00%. The current Forward Dividend Yield % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Trellus Health (LSE:TRLS), the current Forward Dividend Yield % is 0.00% as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Trellus Health PLC is commercializing the provision of digital chronic condition management solutions for employers and health plans that utilize the scientifically validated GRITT resilience-based methodology and a proprietary HIPAA-compliant technology platform called TrellusElevate to coordinate and deliver personalized care. The company is initially focused on Inflammatory Bowel Diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis but considers its approach to have potential utility and demand across many chronic conditions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:TRLS has been successfully added to your 
